Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-001927-36-IT
EUCTR2007-001927-36-IT
Active, Not Recruiting
N/A

Early ultrasonography role by Contrast enhanced ultrasonography ( CEUS) evaluating therapy effectiveness in patients with hepatic metastasis of colorectal cancer treated with antiangiogenetic drug. - ND

AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI0 sitesJune 13, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsmethastatic colorectal cancerMedDRA version: 9.1Level: LLTClassification code 10061045Term: Colon neoplasm
DrugsSONOVUE*1FL 8MCG+1SIR 5ML+ADAT

Overview

Phase
N/A
Intervention
Not specified
Conditions
methastatic colorectal cancer
Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Status
Active, Not Recruiting
Last Updated
12 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 13, 2007
End Date
TBD
Last Updated
12 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Eligibility Criteria

Inclusion Criteria

  • •1\. Age \> 18 years 2\. Hystologicaly of colorectal adenocarcinoma 3\. Not resectable hepatic metastasis 4\. Diameter lesions \> 5 millimeters ( at least one lesion) 5\. Not preceding chemotherapy for metastatic disease. 6\. Signed informed consent
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •A)Patients with contraindications to use of Sonovue 1\. Recent Cardiac infarction and frequent and/or several angina cordis events or thoracic ache. 2\. Recent surgery upon the coronary arteries 3\. Recent electrocardiogram abnormalities 4\. Frequent and/or several angina cordis events or thoracic ache in the latest week 5\. Cardiac Failure ; severe arhythmia; cardiac right\-to\-left shunt 6\. Serious pulmonary artery hypertension; not controlled arterial hypertension 7\. Adult respiratory distress syndrome

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
N/A
Contrast enhanced ultrasonography effectiveness in early evaluating of the response to the Sunitinib in the patients with advanced GIST. A pilot study - NDGastrointestinal stromal tumor (GIST)MedDRA version: 9.1Level: LLTClassification code 10061174Term: Gastrointestinal neoplasm
EUCTR2007-001928-12-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Recruiting
N/A
Preliminary study of contrast enhanced ultrasonography using sonazoid and forward-viewing endoscopic ultrasonography for the colorectal diseasecolorectal disease
JPRN-UMIN000036214Department of Endoscopy, Nagoya university hospital24
Not Yet Recruiting
N/A
Contrast Enhanced Ultrasound imaging to support prostate cancer brachytherapy treatment and follow up after treatmentprostate cancerprostate carcinoma10038588
NL-OMON30917Academisch Medisch Centrum10
Completed
Phase 4
IRB 14-009240, Does CEUS Positively Influence Selection of Biopsy Sites When Evaluating Transplant Kidneys?Transplantation, Kidney
NCT02625428Mayo Clinic40
Recruiting
N/A
Contrast enhanced ultrasound imaging to support prostate cancer brachytherapy treatment and follow up after treatment.Prostate and cancer.
NL-OMON22373Academic Medical Centre Amsterdam, department of urology and department of radiotherapy10